微芯生物拟以8000万元—1.2亿元回购公司股份;荃信生物首款创新药上市申请获受理 | 医药早参

每日经济新闻
Mar 11

| 2026年3月11日星期三 |  NO.1 博瑞医药拟对参股公司徕特康增资3000万元  博瑞医药发布公告称,公司拟对参股公司徕特康增资3000万元,其中认缴徕特康新增注册资本46.12万元,剩余部分计入标的公司的资本公积金。本次增资前公司持有徕特康11.51%股权,增资后持有徕特康16.52%股权。  点评:博瑞医药拟对徕特康增资3000万元,将持股比例从11.51%提升至16.52%,助力...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10